D. Mauss

Prophylactic or Simultaneous Administration of Recombinant Human Granulocyte Colony Stimulating Factor in the Treatment of Group B Streptococcal Sepsis in Neonatal Rats

M. Cairo, K. Norris, C. Ven, 1990, Pediatric Research.

Modulation of Neonatal Myelopoiesis in Newborn Rats after 7 Days' Administration of Either Granulocyte-Monocyte Colony Stimulating Factor or Interleukin-3

M. Cairo, S. Gillis, C. Ven, 1991, Pediatric Research.

Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.

M. Cairo, J. M. Plunkett, D. Mauss, 1990, Blood.

Lymphokines: enhancement by granulocyte-macrophage and granulocyte colony-stimulating factors of neonatal myeloid kinetics and functional activation of polymorphonuclear leukocytes.

M. Cairo, S. Kommareddy, C. Vandeven, 1990, Reviews of infectious diseases.

Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Primes Neonatal Granulocytes for Enhanced Oxidative Metabolism and Chemotaxis

M. Cairo, L. Sender, C. Ven, 1989, Pediatric Research.

Modulation of neonatal rat myeloid kinetics resulting in peripheral neutrophilia by single pulse administration of Rh granulocyte-macrophage colony-stimulating factor and Rh granulocyte colony-stimulating factor.

M. Cairo, K. Norris, S. Kommareddy, 1991, Biology of the neonate.

Streptococcus sepsis stimulating factor to newborn rats : modulation of neonatal Seven-day administration of recombinant human granulocyte colony

M. Plunkett, D. Mauss, 2003 .